|
Background Information of Panelists 3rd Annual Global Private Equity Conference 2002: The Year In Review & Outlook 2003 |
||
|
| DATES:
|
October
17th & 18th, 2002 (Metropolitan
Club, New York City)
___________________________________________________________________ |
DAY 1: 7:30 - 8:30 AM |
Thursday, October 17th, 2002 ___________________________________________________________________ Registration and Breakfast ___________________________________________________________________ |
|
8:30 - 9:00 AM |
Keynote
Speaker: |
|
9:00 - 10:00 AM |
Panel I World-class Buy Out Investors Reveal Strategies For Success Under Volatile Market Conditions And Describe Their Most Recent Transactions Panelists: Apollo Management, L.P Marc J. Rowan, Partner, Apollo Management Marc J. Rowan is a founding partner of Apollo Management, L.P., a private investment partnership that manages a series of institutional funds focused on complex equity investments, leveraged buyouts and corporate reorganizations. Prior to joining Apollo, Mr. Rowan was a member of the mergers and acquisitions department of Drexel Burnham Lambert, Incorporated, with responsibilities in high yield financing, transaction idea generation and merger structure negotiation. Mr. Rowan currently serves on several boards of directors including: Samsonite Corporation, a leading manufacturer of luggage; Vail Resorts, Inc., the owner and operator of the Vail, Beaver Creek, Keystone and Breckenridge ski areas; Quality Distribution, Inc., the leading bulk chemical transport company in the U.S.; NRT, Inc., the leading national real estate brokerage company, National Financial Partners, Inc., a distributor of financial products to affluent individuals and small and medium sized businesses, Rare Medium, Inc., a fast growing, leading edge provider of internet e-commerce design solutions and Wyndham International, which owns, leases, manages and franchises primarily upscale and luxury hotel and resort properties. Mr. Rowan has previously served on the board of directors of New World Communications, Inc., Furniture Brands International and Culligan Water Technologies. Mr. Rowan is also active in charitable activities. He is a founding member and serves on the executive committee of the Youth Renewal Fund and is a member of the board of directors of the National Jewish Outreach Program and the Undergraduate Executive Board of The Wharton School. Mr. Rowan Graduated Summa Cum Laude from The University of Pennsylvania’s Wharton School of Business with a B.S. and an MBA in Finance. For more information, visit www.apollolp.com Blackstone Group Howard Lipson, Senior Managing Director, Blackstone Group Howard Lipson is a Senior Managing Director in the Private Equity group. Since joining Blackstone in 1988, Mr. Lipson has been responsible for and involved in the execution of Blackstone’s purchase of Six Flags (a joint venture with Time Warner), the acquisition of Graham Packaging, and Blackstone’s investments in Universal Orlando, Allied Waste, Volume Services America, Ritvik Toys, UCAR, US Radio and Transtar among others. Before joining Blackstone, Mr. Lipson was a member of the Mergers & Acquisitions Group of Salomon Brothers Inc. Mr. Lipson received a BS in Economics from the Wharton School of the University of Pennsylvania, where he graduated with honors. He currently serves as a Director of Allied Waste Industries, Inc., Graham Packaging, Volume Services America, Rose Hills, Ritvik Toys and Universal Orlando. Since
1985, without deviating from Blackstone's core beliefs, the firm
has raised approximately $24 billion for alternative asset
investing across its Private Equity, Real Estate, Mezzanine
Financing, and Marketable Alternative Investments groups. The
Mergers & Acquisitions and Restructuring &
Reorganization advisory businesses have handled assignments well
in excess of $350 billion. Up to December 31, 2001, Blackstone
had invested total capital of $8.6 billion in 180 transactions
with a total enterprise value of $72 billion through its Private
Equity, Real Estate, and Mezzanine funds. Kohlberg & Company, L.L.C. is one of the most widely known U.S. private equity firms specializing in middle market investing. Since its founding in 1987, the firm’s objective has been to realize substantial capital gains through control investments in a diversified portfolio of companies. The firm’s goals are to increase revenues through enhanced marketing, investment in new products and selected strategic acquisitions, and to increase profitability through cost reductions and operational improvements. The firm has completed 30 platform investments and more than 60 add-on acquisitions with an aggregate transaction value in excess of $4.0 billion. Selected industries Kohlberg has invested in include: general manufacturing, machinery and equipment, building products, food and food related, aerospace/defense, healthcare, consumer products, automotive, and value added services. For more information,
visit www.kohlberg.com For more information,
visit www.morgenthaler.com
The Comptroller is the chief fiscal officer of the State of New
York, the administrative head of the State and Local Retirement
Systems, and the sole trustee of the State’s Common Retirement
Fund with assets of $112 billion.
As Counsel, Ms. Chester was responsible for the
supervision of the division of Legal Services which has 35
attorneys and 23 support staff who serve the Comptroller in a
variety of capacities. As the
Common Retirement Fund’s Director of Private Equity, Ms.
Chester oversees a portfolio of over $15.8 billion in
Alternative Investments and Opportunistic Real Estate.
The portfolio includes venture capital, corporate
finance, special situation, and international funds as well as
certain pooled real estate transactions.
Prior to her appointment as Counsel to the Comptroller, Ms.
Chester served as general counsel to the New York City
Comptroller from 1990-1993.
Before joining the City Comptroller’s Office, Ms.
Chester served as an associate and later partner in the firm of
Berger & Steingut. Between
1977-1981, she worked for the U.S. Securities and Exchange
Commission – first as a branch attorney in the Division of
Corporate Finance; then as a special counsel of the SEC’s
Office of Small Business Policy.
Ms. Chester is the author of Regulation D, promulgated
under the Securities Act of 1933. |
10:00 - 10:30 AM |
Q&A ___________________________________________________________________ |
10:30 - 11:30 AM |
Panel II The World's Leading Biotechnology And Life Science Investors Describe Their Investment Process, Analyze Deal Opportunities And Highlight Sectors With The Most Potential For Growth Panelists: Atlas Venture Peter Barrett, Partner, Atlas Venture Peter Barrett joined Atlas Venture in 2002. Previously, he was a co-founder and former Executive Vice President and Chief Business Officer of Celera Genomics, positions he had held since 1998. Within two years of the founding of the company, Celera announced the first successful sequencing of the human genome. At Celera, Peter helped launch the company as a publicly traded entity in 1999 and helped transform Celera into a leading force within the biotechnology industry, with annual revenues of over $100 million. He led Celera’s expansion into drug discovery and development, forging strategic alliances with technology companies and leading the acquisition of Axys Pharmaceuticals. Before Celera, Peter held senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. During his tenure, he expanded the life science business units through a series of licensing agreements, partnerships and acquisitions including: Applied Biosystems, Tropix, Molecular Informatics, PerSeptive Biosystems, and Genscope. Also during this time, Peter co-founded Celera Genomics with Dr. J. Craig Venter and the Applera Corporation management team. Additional managerial roles included Executive Vice President of the Applied Biosystems Division of Perkin-Elmer. Peter received his Bachelor of Science in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Ph.D. in analytical chemistry from Northeastern University. He also completed Harvard Business School’s Management Development Program. Peter currently serves as a board member of HuBit Genomix and Genecore. Prior board appointments include Chairman of the Board of the Analytical and Life Science System Association, Roche Strategic Alliance, and Sciex Joint Venture. Atlas Venture is the leading international early-stage venture capital firm, investing in communications technology, information technology and life sciences companies. With investing offices in Boston, London, Menlo Park, Munich, Paris and Seattle, Atlas Venture divides its investments between the United States and Europe. Founded in 1980, Atlas Venture has organized six international funds, and currently manages $2.4 billion in committed capital. The Atlas Venture investment team is comprised of seasoned operating executives and career venture capitalists who have been deeply involved in the formation and development of more than 300 companies worldwide. For more information , visit www.atlasventure.com. Boston Millennia Partners Dr. Rob Mashal, Partner, Boston Millennia Partners Rob focuses on Life Sciences opportunities, primarily drug discovery and development and enabling technologies for the drug development process, including genomics, systems biology, and chemical genomics. Prior to joining Boston Millennia Partners, Rob was a Program Executive for the MDR program at Vertex Pharmaceuticals (Nasdaq: VRTX). He was also a member of the Joint Research Committee for the $800 million Vertex-Novartis kinase collaboration. At Vertex, Rob gained extensive experience in overseeing drug discovery and development programs, and implementing strategic business partnerships. Prior to joining Vertex, Rob was an associate at McKinsey & Co. where he advised a variety of clients in the healthcare/life sciences industries. Before that, he was an attending physician at the Dana-Farber Cancer Institute where he conducted research on molecular genetics. He did his internal medicine residency at the University of California, San Francisco and completed his medical oncology fellowship at the Dana-Farber Cancer Institute. He holds a B.A. and M.D. from Johns Hopkins University. Boston Millennia Partners provides private equity financing to high growth companies in the telecommunications, information technology, and healthcare and life sciences industries. Our team brings over seventy-five years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance, engineering, operations, and law provides significant value to the companies in which we invest. Over the past twenty years, we have developed an investment approach that centers on active participation with our portfolio companies. Our goal is to be valuable and effective investors while at the same time establishing productive relationships with our business partners that create long term value. We seek to partner with entrepreneurs who share our goal of building enduring, large-scale businesses. Our history reflects an entrepreneurial spirit that has guided our investment philosophy since 1979. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our present capital base to over $700 million. As our firm has grown, we have built a network that spans the globe. Investors from a dozen countries have entrusted us to manage capital on their behalf For more information, visit www.millenniapartners.com JP Morgan Partners Dr. Srinivas Akkaraju, Principal, JP Morgan Partners Srinivas joined the Life Sciences team in the Healthcare Group at JPMorgan Partners, LLC in April '01. From October '98 to April '01, Srinivas was in Business and Corporate Development at Genentech, Inc., most recently as Senior Manager. There he was responsible for worldwide partnering activities including technology access deals, in-licensing of early and late-stage therapeutics, and out-licensing of Genentech development projects. In addition to his business development role, Srinivas also served for the last year as Project Team Leader for one of Genentech's clinical development products. During this time, Srinivas was also a founding member of BioStreet, an online marketplace for biotech opportunities. Prior to joining Genentech in 1998, Srinivas was a graduate student at Stanford University, where he earned his M.D. and Ph.D. in Immunology. Srinivas earned his undergraduate degrees in Biochemistry and Computer Science from Rice University in 1990. He is currently a Director of Eyetech Pharmaceuticals. JPMorgan Partners ("JPMP") is a global private equity organization which provides equity and mezzanine capital financing primarily to private companies. We invest throughout the entire life cycle of the business development process. Our investment mandate permits maximum flexibility in supporting the equity needs of businesses worldwide. JPMP strives to be management's partner of choice. JPMP complements management in their pursuit to expand globally, consolidate industries, enhance technology, access financing markets in the most efficient manner and build and maintain top personnel. With over 150 investment professionals, JPMP invests globally. JPMP currently manages an $31 billion portfolio which includes $20 billion of direct equity and mezzanine investments. JPMP also manages $11 billion of other alternative assets and high yield/leveraged loan products. Since our inception in 1984, JPMP has closed more than 1,800 direct equity and mezzanine transactions. JPMP's diversified portfolio includes board seats in over 300 companies. JPMP's primary limited partner is J.P. Morgan Chase & Co., a leading global financial services firm with assets of $741 billion and operations in more than 50 countries. Other prominent institutions and individuals are also investors in JPMP. For more information, visit www.JPMorganPartners.com Perseus-Soros Biopharmaceutical Fund Dr. Drew Schiff, Managing Director, Perseus-Soros Biopharmaceutical Fund Dr. Schiff joined Perseus-Soros in September of 1999 and currently serves as a Managing Director. Over the last 10 years, Dr. Schiff has practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine. In addition, he has also been a partner of a small family run investment fund, Kuhn, Loeb & Co. Dr. Schiff received his MD from Cornell University Medical College and his MBA from Columbia University. His bachelor’s degree in neuroscience was awarded with honors by Brown University. He currently serves on the board of directors of Adams Laboratories, Barrier Therapeutics, Bioenvision, and Myogen. Perseus-Soros Biopharmaceutical Fund was established in 1999 by affiliates of Perseus, L.L.C. (Perseus) and Soros Private Funds Management, LLC (SPFM) to make investments in life science companies developing biopharmaceutical products and creating businesses based on advanced life science technologies. Perseus, L.L.C. is a merchant back and private equity fund management company headquartered in Washington, D.C. operating funds with over $1 billion of private capital. Perseus has extensive experience in structuring financial investments. Perseus' funds include Perseus 1996, Perseus Capital, Perseus 2000, and the Perseus Acquisition/Recapitalization Fund. Perseus also has extensive investment effort in advanced technologies in the energy field. SPFM is an affiliate of Soros Fund Management, L.L.C. (SFM) based in New York and London. The Soros organization has been one of the world’s most successful investors during the past 21 years in a variety of markets, securities, investment vehicles (including private equity), and industries in more than 45 countries. For more information, visit www.psbiofund.com Sprout Group Ron Hunt, Partner, Sprout Group Ron Hunt is a partner at the Sprout Group and joined the firm in early 1998. His focus is early and later stage investments in life sciences and health care technologies. Prior to joining Sprout, Ron was a consultant with Coopers & Lybrand Consulting and The Health Care Group for a combined 4 years. His consulting work focused on strategic and operational engagements for clients in the pharmaceutical, medical device, and health care services industries. Prior to entering the consulting field, Ron held a number of sales and marketing positions for a combined 8 years with Johnson & Johnson and SmithKline Beecham Pharmaceuticals. Ron is a graduate of The Wharton School (MBA) and Cornell University (BS).
Since raising our first venture fund of $12 million more than 30
years ago, Sprout has invested in more than 350 companies whose
combined revenues now exceed $50 billion. Our current fund,
Sprout Capital IX, totals $1.6 billion. Sprout is committed to
building a portfolio that is foucsed on technology
investments and is balanced by stage and industry, including
early stage, growth, mezzanine, and buyout investments in the Datacom
& Telecom, E-Commerce,
Services,
Healthcare
Technology, Software
and Technology
industries. While we are not typically providers of seed
capital, Sprout is very active as early stage investors.
Sprout Capital IX was raised in late 2000, and is $1.6
billion. The fund is capitalized primarily by commitments
from large corporate pension funds, public funds, insurance
companies, endowments, and other private investors - 60% of whom
have invested in previous Sprout funds. Our roster of limited
partners includes AIG, Brinson Partners, The Common Fund,
Equitable Life, Harbourvest, St. Paul Fire & Marine, and
Toronto Dominion Bank, as well as the pension funds of BP(ARCO),
Honeywell, the states of Michigan, Virginia, Washington, and
others. Moderator/Limited Partner: Invesco Private Capital Mary Frances Kelley, General Partner, Invesco Private Capital Mary Frances Kelley, General Partner, is a nationally recognized small business expert and lecturer, and has been a consultant to two Fortune 100 financial services firms. Mary joined Sovereign Financial Services (now INVESCO Private Capital) in 1994. She began her career in 1976 with Deloitte & Touche in the Audit and General Service department. Mary founded her own full service accounting firm in 1980. Her business acumen and leadership have been recognized by both the Reagan and Clinton administrations. She was a participant in President-elect Clinton’s Economic Summit, and has served on an advisory board to the Kansas City Federal Reserve Bank. She was one of eleven commissioners for the White House Conference on Small Business in 1995. She has extensive experience in business valuation and strategic planning matters. In addition, she has worked with a number of businesses, foundations and endowments with regard to the development of systems, reporting and internal controls. Mary serves on several partnership advisory boards including Telecom II & III, CHL Medical, Healthcare Ventures and Apex. She received a B.A. in Secondary Education from the University of New Mexico in 1971. Her business and civic leadership include a term as the national president of the National Association of Women Business Owners. Mary served on the Board of the National Federation of Independent Business, this country’s largest small business organization (600,000 members) with a presence in all 50 states from 1988 to 1998. She is a licensed Certified Public Accountant in the State of Colorado. ___________________________________________________________________ |
11:30 - 12:00 Noon |
Q&A ___________________________________________________________________ |
12:00 Noon - 1:00 PM |
Panel III Global Media & Communications Titans Discuss Investment Opportunities In High Growth Media Industry Segments, Including Broadcasting, Cable & Entertainment, Publishing, Information Services, and Digital Rights Management Panelists: |
1:00 - 2:00 PM |
Luncheon ___________________________________________________________________ |
|
2:00 - 3:00 PM |
Panel IV Premier Venture Capitalists Reveal Their Recent Investments & Identify Sectors For Growth For 2003 Panelists: ABS Capital Partners Dean Goodermote, Partner, ABS Capital Partners Dean joined ABS in 2001 as a Venture Partner to work closely with portfolio companies in the software and services space. With over 15 years of senior management experience, he has led a number of technology companies through their expansion stages. Before joining ABS, Dean was the CEO of ABS portfolio company Clinsoft (formerly Domain Pharma), a leader in clinical trial and biopharmaceutical information platforms. Dean was instrumental in re-focusing the company's strategy and growing revenues. In August 2001, Clinsoft merged with Phase Forward to create the dominant software company for clinical development. Prior to Clinsoft, Dean was the CEO of Process Software, a developer of Internetworking software, where he increased revenues and launched the company's key new product. During this time, he also served as Chairman and President at Domain Solutions Corporation. Before that, as President and Chairman of PSDI, now called MRO Software, he led the company through a successful IPO and secondary offering.
ABS
Capital Partners
was founded in 1990 to invest in mid- to later- stage
companies with scalable, sustainable business models that
create long-term value. The firm's investment strategy focuses
on companies providing software, services and infrastructure
to Global 2000 corporations, healthcare enterprises and
media/communications companies. ABS Capital leverages over 100
years of combined experience among its partners, and offers a
range of investment structures, including expansion
financings, management buyouts and recapitalizations for
growth companies. The partners' extensive knowledge of equity
capital markets allows them to provide strategic guidance to
companies and establish them as significant market leaders.
With $1.4 billion under management, ABS has seven investing
partners, and has offices in Baltimore, San Francisco and
Northern Virginia. Over the past ten years, ABS Capital has
invested in over 60 portfolio companies, including Transaction
System Architects, Inc (NASDAQ: TSAI), DoubleClick, Inc
(NASDAQ: DCLK), SBA Communications Corporation (NASDAQ: SBAC),
AMISYS Managed Care Systems Corporation (now McKesson HBOC)
(NYSE: MCK) and OTG Software, Inc. (NASDAQ: OTGS).
For more information, visit www.abscapital.com Crimson Ventures John-Paul Ho, Partner, Crimson Ventures John-Paul Ho is the founder of Crimson. John-Paul led Crimson’s investments in Timogen, Polivec, @Road, TransMedia and Transmeta, amongst others. He was previously in charge of the technology investment banking efforts of CS First Boston throughout Asia, and was also a Vice President in the technology investment-banking group in New York. He was also previously a member of the Mergers and Acquisitions department of Goldman Sachs. John-Paul received an MBA from Harvard Business School, where he graduated with distinction and was awarded a Dean's Doctoral Fellowship. He also received an undergraduate degree in Engineering and Applied Sciences from Harvard University, where he graduated summa cum laude and was elected Phi Beta Kappa. Crimson is a private equity firm headquartered in Silicon Valley with over $500 million under management. Crimson @Velocity invests in U.S. and Pacific Rim companies that enable Global 1000 corporation to reduce costs and improve operational efficiencies. We focus on investments in enterprise software, outsourced services and manufacturing, infrastructure systems, components and semiconductors. We have an active presence in the US and throughout the Pacific Rim. We leverage our entrepreneurial and operational experience in technology to help build companies in the U.S. and Asia. Crimson helps companies to strengthen business strategies, build management teams, and access customers and strategic partners. Our capabilities enable us to help grow successful companies and position them in public markets. For more information, visit www.crimsonventures.com General Atlantic Partners Drew Pearson, Principal, General Atlantic Partners
Drew Pearson is a Principal at General Atlantic Partners, LLC, a
worldwide private equity firm, where he has worked since 1996.
Mr. Pearson is based in Greenwich, CT and concentrates on
portfolio company support. Mr. Pearson has worked on over $150
million in transactions in the Enterprise Software and IT
Infrastructure markets, including Manugistics, EXE Technologies,
and Talus Solutions. Prior to joining General Atlantic Mr.
Pearson was a business analyst with McKinsey & Company, Inc.
where he worked with Fortune 500 businesses in the technology
and financial services industries. Mr. Pearson holds a MA/BA in
Regional Science from The School of Arts & Sciences at the
University of Pennsylvania, and a BS in Finance from The Wharton
School at the University of Pennsylvania. For
more information, visit
www.gapartners.com. |
3:00 - 4:00 PM |
Schroder Venture Partners LLC ("Schroder Ventures US"
or "SVUS") is one of six affiliated international
private equity organizations advising over $7.5 billion of funds
under management in 11 offices located in North America, Europe,
and Asia. SVUS is focused on middle market investment
opportunities in the media, business services, communications
and technology sectors in partnership with management. Current
investments include Mesa Communications. Group LLC, a wireless
tower operator, ThoughtWorks, Inc., a custom software
development company, and Memec, a global specialty semiconductor
distributor. |
4:00 - 4:15 PM |
CEO Keynote Speaker Mingchen Zhou, Chairman of the Board. China National Cereals, Oils and Foodstuffs Import and Export Corporation (COFCO) Chairman Zhou graduated from Beijing Institute of Foreign Trade (now the University of International Business and Economics) with a major in Japanese. Before Zhou joined COFCO in 1992, he was vice-president of China National Metals & Minerals Import & Export Corporation, President of China National Instrument Imort & Export Corporation. He has more than 30 years of experience in international trade and management expertise. COFCO is one of Asia’s largest conglomerates encompassing trade, industry, finance, information, service and scientific research COFCO has been ranking among the Global Top 500 Enterprises on Fortune magazine since 1994. COFCO ranks NO. 9 on the list of China Top 500 Enterprises released by China Enterprise Confederation and China Enterprise Directors Association on Aug. 29th, 2002. ![]() There are four business groups under COFCO. COFCO Grains and Oils Import and Export Company is engaged in the import and export business of agricultural commodities including grains, oils and sugar. COFCO International, a Hong Kong-list company (HKSE Code: 506), is in the line of food trading and manufacturing business. Top Glory International, also a Hong Kong-list company (HKSE Code: 268), mainly engages in the investment and management of real estate, hotels and properties. COFCO Development Company cultivates potential business. COFCO serves as an important link between China’s grain, oil and food market and the international market. It is the COFCO channel that enables various agricultural products and foods of China enter the international markets, and vice versa. COFCO Group also produces quality and famous products such as Great Wall wine, Fortune, edible oil, Le Conte chocolate in China. COFCO is the leader in the industries such as flour, malting barley, beverage, metal coating and printing, and tops and caps manufacturing. The target of COFCO is to grow into a prestigious multinational company, with strong market competency and industrial influence, delivering quality products and services to China and the rest of the world in the future. COFCO welcomes Global Venture Network and private equity investors to China.
For more
information,
visit
www.cofco.com |
4:15 - 5::30 PM DAY 2: |
Networking
Reception -- A Selection of Fine Cigars Provided by
Davidoff
__________________________________________________________________ Friday, October 18th, 2002 ___________________________________________________________________ |
7:30 - 8:30 AM |
Registration and Breakfast ___________________________________________________________________ |
8:30 - 9:00 AM |
Welcome Private Equity Investor Welcome James Hahn, Chairman, Global Private Equity , & Partner, Alpine Alternative Assets Keynote Speaker V. Peter Harder, Deputy Minister, Industry Canada V. Peter Harder was appointed Deputy Minister, Industry Canada, in March 2000. Mr. Harder was first appointed Deputy Minister in 1991. He has served in a number of departments including Treasury Board and Citizenship and Immigration. Mr. Harder is also a member of the Board for the Business Development Bank of Canada, the National Research Council, the Communications Research Centre and the Canadian Tourism Commission. He is also a member of the Canadian Space Agency Advisory Council and an honorary Governor of the Public Policy Forum. Mr. Harder was awarded the Prime Minister's Outstanding Achievement Award for public service leadership in May of 2000. In November of 2001, Mr. Harder was Appointed by Secretary General Koffi Annan to the United Nations ICT Task Force on digital divide and development. Mr. Harder was born in Winnipeg, Manitoba in 1952 and was raised in Vineland, Ontario. He has a Bachelor of Arts (Honours) in Political Science from the University of Waterloo and a Master of Arts from Queen's University. For more information, visit, www.ic.gc.ca ___________________________________________________________________ |
9:00 - 10:00 AM |
Panel VI Limited Partners Define Their Criteria For Investments And Provide Insights On Fund Raising For Private Equity Funds Limited Partner Panelists: Adams Street Partners Dennis P. McCrary, Partner, Adams Street Partners As Head of the U.S. Partnership Team, Mr. McCrary is involved in all aspects of the Partnership Team’s investment activities. He is responsible for originating, analyzing, investing in and actively monitoring investments in all subclasses of fund investments. In addition, he works with the Partnership Team and the Fund Management Team to serve the needs of existing and prospective Adams Street Partners clients. Mr. McCrary joined Adams Street Partners in 2002 after 20 years in various positions at the Bank of America. Most recently, Mr. McCrary was a Managing Partner of the Chicago-based team that originated, structured and managed direct equity and mezzanine investments. A majority of these investments were made in conjunction with independent private equity limited partnerships. Prior to joining the equity and mezzanine investment business in 1995, Mr. McCrary was a Managing Director at Continental Bank(acquired by Bank of America) and led several businesses involving leveraged finance origination and portfolio management, loan syndications, and private debt placements. In these positions Mr. McCrary worked extensively with private equity firms, corporate clients, and a variety of institutional investors. Mr. McCrary received the following degrees: Michigan State University, BA, 1978 , University of Michigan, MBA, 1980. Adams Street Partners is a leading private equity investment firm, providing both partnership and direct investment services to institutional clients. Adams Street Partners is an independent, employee-owned entity, resulting from the January 2001 spin-out of the Private Equity Group of UBS Global Asset Management/Brinson Partners, Inc. The private equity portfolios continue to be managed in the same manner and style, and by the same people, as they have over the past two decades. Adams Street Partners is headquartered in Chicago with an office in London. Adams Street Partners is one of the largest managers of private equity partnership investments in the United States and has one of the longest histories, with $6.6 billion under management. Together with its predecessor organizations, Adams Street Partners has been investing in private equity partnerships since 1979 and managing direct investments in private equity since 1972. Adams Street Partners is well known internationally for its continuous commitment to, and deep understanding of, the private equity industry.
For
more information, visit www.AdamsStreetPartners.com
For
more information, visit www.hamiltonlane.com
Ms. Kinner runs RBC Leveraged Capitals’ Alternative
Investment Management group.
Prior to joining RBC in 2002, she was with JPMorgan
Chase and its predecessor organizations for over 22 years,
having originally joined Manufacturers Hanover Trust Co. as a
management trainee after business school.
From 1998 until she left in late 2001, she was head of
the group within Chase Alternative Asset Management, Inc.
which oversaw clients’ multi-manager private equity
portfolios.
She was responsible for conducting due diligence and
making investment recommendations for Chase’s private equity
fund of funds, as well as for day to day management of over US
$1 billion in the investment portfolios.
Prior to joining Chase Alternative Asset Management,
Ms. Kinner was the Managing Director of Chemical Bank’s
Connecticut private banking market from 1995-1997 and Group
Senior Credit officer of Chemical Private Banking from
1992-1995.
Prior to her private banking assignments, she held
various management positions in Corporate Banking, Acquisition
Finance and Risk Management.
Ms. Kinner holds and A.B. degree in Economics and
Psychology from Smith College and and M.B.A. from the
Whittemore School at the University of New Hampshire.
For
more information, visit www.rbccm.com
For more information, visit www.TIAA-CREF.org
Mr. van Horne is responsible for Abbott’s fund development
and client services activities.
Mr. van Horne has over 15 years of involvement with
private equity in the U.S. and overseas.
Abbott is one of the leading independent firms investing
in private equity partnerships and co-investments, with over $5
billion under management. Prior
to joining Abbott in 2001, Mr. van Horne was a Managing Director
of AIG Capital Partners, Inc. (a subsidiary of American
International Group, Inc.), which, together with its affiliates,
manages over $8 billion in private equity.
At AIG, he was responsible for fund development and
client services and served on the investment committees for
several of its direct investment funds and funds of funds.
Prior to joining AIG, Mr. van Horne was Managing Director
of Creditanstalt International Advisors, where he established
and managed its private equity investment activities.
He also was at Bankers Trust in its Merchant Bank, its
M&A Group and other functions in New York and London and at
UBS Securities in New York.
Mr. van Horne received his B.A. in Sociology from the
University of Pennsylvania.
|
10:00-10:30 AM |
Q&A ___________________________________________________________________ |
10:30-11:30 AM |
Panel VII Billion Dollar Investors Analyze the Year In Review And Make Their Forecasts For 2003 And Beyond Panelists: Draper Fisher Jurvetson Timothy Draper, Founder & Managing Director, Draper Fisher Jurvetson Timothy C. Draper is the Founder and Managing Director of Draper Fisher Jurvetson. On behalf of Draper Fisher Jurvetson, Mr. Draper serves on the boards of Chroma Graphics, Homestead, meVC.com, PLX Technologies (PLXT), and Phosistor. His original suggestion to use "viral marketing" in web-based e-mail to geometrically spread an Internet product to its market was instrumental to the successes of Hotmail and Four11. Previous successes included Parametric Technology (PMTC), Tumbleweed Communications (TMWD), GoTo.com (OVER), Digidesign (AVID), Preview Travel (TVLY), Four11 (YHOO), Combinet (CSCO), and Redgate (AOL). Mr. Draper launched the Draper Affiliate Network, a group of regional early-stage venture capital funds, including Zone Ventures in Los Angeles, Draper Atlantic in Reston, VA, Draper Triangle in Pittsburgh, PA, Wasatch Ventures in Salt Lake City, UT, Timberline Ventures in Portland, OR, Polaris Fund in Anchorage, AK, and Draper Fisher Jurvetson Gotham in New York. He has a BS in Electrical Engineering from Stanford University, and an MBA from Harvard Business School. As an advocate for entrepreneurs, he has been published in The Wall Street Journal, San Francisco Examiner, San Jose Mercury News, Upside, The Red Herring, and the Congressional Record. Mr. Draper is also the creator of Tim Draper's BizWorld, a course used to train young entrepreneurs. He served on the California State Board of Education and launched a state wide cyber-initiative on school choice for the California General Election in November of 2000. Draper Fisher Jurvetson is the leader in start-up venture capital, having invested in over 150 high-tech companies. In the majority of cases, we are the lead investor for a company's first round of financing. We focus on information technology businesses with enormous market potential. Our role is to help entrepreneurs achieve their maximum potential through team building, partnerships, advice and support, as well as investments. By pursuing a people-focused approach to venture capital investing, we continue to fund entrepreneurs with the energy, vision, experience, and desire to build great companies. The Draper name is well known in the venture capital industry. General William H. Draper Jr. became the first professional West Coast venture capitalist when he founded Draper, Gaither & Anderson in 1958. Formerly Undersecretary of the Army, General Draper was responsible for economic reconstruction of Germany and Japan under the Marshall Plan. His son, William H. Draper III has a long history in the venture capital business. In 1962, with Partner Franklin "Pitch" Johnson, he started Draper & Johnson Investment Company. In 1965, he founded Sutter Hill Ventures which he managed with great success until 1981 when he was appointed Chairman of the U.S. Export-Import Bank. In 1985, he was selected to be Administrator and CEO of the United Nations Development Program ("UNDP"). While in the venture capital business, Bill Draper was a founding investor in Apollo Computer (acquired by Hewlett Packard), Dionex, Integrated Genetics (Genzyme), Quantum, Qume (I.T.T.), Activision (Mediagenic), Xidex (Eastman Kodak), Measurex, Hybritech (Eli Lilly), and LSI Logic. In 1995, he returned to venture capital by founding Draper International which will focus on venture investments in India. In 1985, Timothy C. Draper left Alex. Brown & Sons to become the third generation of venture capitalists in his family with the formation of Draper Fisher Jurvetson. Tim restructured a family-owned Small Business Investment Company (SBIC) that had been set up by his father in 1979.
For
more information, visit www.dfj.com
Trident Capital For
more information, visit www.tridentcap.com. |
11:30 - 11:45 AM |
Q&A ___________________________________________________________________ |
11:45 - 12:00 Noon
REGISTRATION:
VENUE:
|
Closing Remarks ___________________________________________________________________ All amounts are in U.S. Dollars: Online Registration For This Conference Is Now Closed. The Metropolitan Club 1 East 60th Street (at Fifth Avenue) New York, New York 10022 For directions, call: 212-277-8502 Metropolitan Club Dress Code requires jacket and tie for men and no jeans are allowed. Please note that the Metropolitan Club is a PRIVATE CLUB, and admission to the club is restricted to Registered Attendees of Global Venture Network with valid name badges. Please arrange to meet your guests who are not participants of the conference outside of the private club facilities. ___________________________________________________________________ PO Box 735 Alpine, NJ, USA 07620 _________________________________________________________________ * * * * * * * * New York London Shanghai |